A study by researchers at U.S. health insurance and medical services provider Kaiser Permanente, the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University, ...
47 minutes ago
0
0
A new position statement from the International Osteoporosis Foundation's (IOF) Committee of Scientific Advisors Fracture Working Group urges orthopedic surgeons and bone health specialists to work together to assess and ...
6 hours ago
0
1
Globally, the number of people with type 2 diabetes (T2D) is escalating. In Australia, Aboriginal and Torres Strait Islander peoples are four times as likely to die from T2D or experience serious T2D-related disease as non-Indigenous ...
17 hours ago
0
1
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 ...
18 hours ago
0
4
Collagen is a protein found in skin, hair, nails, tendons, cartilage and bones. Our bodies naturally produce collagen using the foods we eat. But in recent years, collagen peptides have gained popularity as a supplement to ...
18 hours ago
0
6
The effect of obesity on unemployment is more than twice as large as previously thought, finds a UK Biobank study of genetic evidence.
Jul 17, 2026
0
4
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
5
For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other glucose-lowering ...
Jul 16, 2026
0
4
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
6
